Related Experiment Video
Updated: Feb 16, 2026

Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling
Muhammad Nazirul Mubin Aziz1, Yazmin Hussin2, Nurul Fattin Che Rahim3
1Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, UPM, Serdang 43400, Selangor, Malaysia. muhammadnazirulmubin@gmail.com.
Abstract:
Osteosarcoma is one of the primary malignant bone tumors that confer low survival rates for patients even with intensive regime treatments. Therefore, discovery of novel anti-osteosarcoma drugs derived from natural products that are not harmful to the normal cells remains crucial. Curcumin is one of the natural substances that have been extensively studied due to its anti-cancer properties and is pharmacologically safe considering its ubiquitous consumption for centuries. However, curcumin suffers from a poor circulating bioavailability, which has led to the development of a chemically synthesized curcuminoid analog, namely (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one (DK1). In this study, the cytotoxic effects of the curcumin analog DK1 was investigated in both U-2OS and MG-63 osteosarcoma cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell death was microscopically examined via acridine orange/propidium iodide (AO/PI) double staining. Flow cytometer analysis including Annexin V/Fluorescein isothiocyanate (FITC), cell cycle analysis and JC-1 were adapted to determine the mode of cell death. Subsequently in order to determine the mechanism of cell death, quantitative polymerase chain reaction (qPCR) and proteome profiling was carried out to measure the expression of several apoptotic-related genes and proteins. Results indicated that DK1 induced U-2 OS and MG-63 morphological changes and substantially reduced cell numbers through induction of apoptosis. Several apoptotic genes and proteins were steadily expressed after treatment with DK1; including caspase 3, caspase 9, and BAX, which indicated that apoptosis occurred through a mitochondria-dependent signaling pathway. In conclusion, DK1 could be considered as a potential candidate for an anti-osteosarcoma drug in the near future, contingent upon its ability to induce apoptosis in osteosarcoma cell lines.
Insights
A novel curcumin analog, DK1, effectively induces apoptosis in osteosarcoma cells. This natural product derivative shows potential as a new anti-osteosarcoma drug by targeting cancer cell death pathways.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Osteosarcoma presents a significant challenge with low survival rates despite intensive treatments.
- Natural products offer a promising avenue for developing safer, effective anti-cancer drugs.
- Curcumin, a natural compound, has known anti-cancer properties but suffers from poor bioavailability.
Purpose of the Study:
- To evaluate the cytotoxic effects of a synthesized curcumin analog, DK1, on osteosarcoma cell lines.
- To determine the mechanism of cell death induced by DK1.
- To assess DK1's potential as a novel anti-osteosarcoma therapeutic agent.
Main Methods:
- Cytotoxicity assessed using MTT assay in U-2OS and MG-63 osteosarcoma cells.
- Microscopic examination of cell death via acridine orange/propidium iodide (AO/PI) staining.
- Flow cytometry (Annexin V/FITC, cell cycle, JC-1) and molecular analyses (qPCR, proteome profiling) to elucidate apoptosis pathways.
Main Results:
- DK1 induced significant morphological changes and reduced cell viability in both osteosarcoma cell lines.
- Apoptosis was confirmed as the primary mode of cell death.
- Upregulation of key apoptotic markers (caspase 3, caspase 9, BAX) indicated a mitochondria-dependent apoptotic pathway.
Conclusions:
- DK1 demonstrates potent apoptosis-inducing capabilities in osteosarcoma cells.
- The observed mechanism involves the mitochondria-dependent signaling pathway.
- DK1 represents a promising candidate for future development as an anti-osteosarcoma drug.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

